MarineMax (HZO) PT Raised to $46 at Stifel
Tweet
Share
E-mailGet Alerts HZO Hot Sheet
Price: $52.25 +0.06%
Rating Summary:
8 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
8 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Stifel analyst Drew Crum raised the price target on MarineMax (NYSE: HZO) to $46.00 (from $33.00) while maintaining a Buy rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Futu Holdings Limited (FUTU) PT Raised to $157 at Citi
- LB Pharmaceuticals Inc (LBRX) PT Raised to $69 at Clear Street
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
